GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin

BACKGROUND: GRHL2 has been shown to function in ovarian carcinogenesis. However, the relationship between GRHL2 and cisplatin (DDP) resistance in serous ovarian cancer (SOC) is not clear. The purpose of this study was to elucidate the function and mechanism of GRHL2 in DDP resistance of SOC. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Yanting, Ding, Yiling, Yang, Mengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335298/
https://www.ncbi.nlm.nih.gov/pubmed/32636649
http://dx.doi.org/10.2147/OTT.S250412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335298/
https://www.ncbi.nlm.nih.gov/pubmed/32636649
http://dx.doi.org/10.2147/OTT.S250412

Ejemplares similares